SCHEMBL3748240

SCHEMBL3748240

CC(C)(C)OC(=O)N1C(=O)CCC1=O

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.43
CHRM2 P08172 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
USP2 O75604 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ESR2 Q92731 1/20 0.37
ELANE P08246 1/20 0.37
CTSK P43235 1/20 0.37
NR1H2 P55055 2/20 0.36
BUB1 O43683 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
DDB1 Q16531 2/20 0.36
CRBN Q96SW2 2/20 0.36
DGAT1 O75907 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19586194 0.92 BCHE (0.41) BCHECHRM2CHRM1CHRM3USP2
SCHEMBL14078162 0.87 BCHE (0.38) BCHECHRM2CHRM1CHRM3USP2
SCHEMBL3670943 0.79 ALDH1A1 (0.36) CHRM2CHRM1CHRM3
SCHEMBL6949587 0.79 MEN1 (0.56) BCHEKDM4E
SCHEMBL29466630 0.79 MEN1 (0.56) BCHEKDM4E
SCHEMBL9480226 0.79 BUB1 (0.36) BCHECHRM2CHRM1CHRM3USP2
SCHEMBL19586495 0.77 CHRM2 (0.41) BCHECHRM2CHRM1CHRM3ELANE
SCHEMBL19586637 0.77 ELANE (0.47) BCHECHRM2CHRM1CHRM3ELANE
SCHEMBL16205507 0.76 KDM4E (0.39) BCHECHRM2CHRM1CHRM3USP2
SCHEMBL31218507 0.76 CHRM2 (0.44) BCHECHRM2CHRM1CHRM3USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119930872-A Catalyst system, prepolymerized catalyst composition and olefin polymerization process 中国石油化工股份有限公司 2025-05-06 CN claimed
CN-119930872-A Catalyst system, prepolymerized catalyst composition and olefin polymerization process 中国石油化工股份有限公司 2025-05-06 CN disclosed
US-20240246967-A1 AXL COMPOUNDS ARCUS BIOSCIENCES, INC. 2024-07-25 US disclosed
US-20240226115-A1 AXL INHIBITOR COMPOUNDS ARCUS BIOSCIENCES, INC. 2024-07-11 US disclosed
EP-4341261-A1 AXL COMPOUNDS Arcus Biosciences, Inc. (US) 2024-03-27 EP disclosed
CN-117337288-A AXL inhibitor compounds 艾库斯生物科学有限公司 2024-01-02 CN disclosed
US-11723897-B2 Fatty acids as anti-inflammatory agents University of Pittsburgh—of the Commonwealth System of Higher Education (US) 2023-08-15 US disclosed
WO-2022246177-A1 AXL COMPOUNDS ARCUS BIOSCIENCES, INC. (US) 2022-11-24 WO disclosed
US-10177410-B2 Lithium secondary battery electrolyte and lithium secondary battery including same SK INNOVATION CO., LTD. (KR) 2019-01-08 US disclosed
US-20160322665-A1 Lithium Secondary Battery Electrolyte and Lithium Secondary Battery Including Same SK INNOVATION CO., LTD. (KR) 2016-11-03 US disclosed
US-20100280259-A1 N-Tert-Butoxycarbonyl-2-Pyrrolidinones and Production Method Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-11-04 US disclosed
US-20090163722-A1 N-TERT-BUTOXYCARBONYL-2-PYRROLIDINONES AND PRODUCTION METHOD THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-25 US disclosed
CN-101415676-A N-tert-butoxycarbonyl-2-pyrrolidinone compounds and method for producing the same SUMITOMO CHEMICAL CO (JP) 2009-04-22 CN disclosed
US-20090023859-A1 POLYOXYALKYLENE DERIVATIVE NOF CORPORATION (JP) 2009-01-22 US disclosed
EP-2008999-A1 N-TERT-BUTOXYCARBONYL-2-PYRROLIDINONES AND PROCESS FOR PRODUCING THE SAME Sumitomo Chemical Company, Limited (JP) 2008-12-31 EP disclosed
EP-0530469-B1 Process for the preparation of organic compounds carrying tert.-butoxycarbonyl groups HOECHST AG (DE) 1995-11-29 EP disclosed
US-5397846-A Process for preparing organic compounds carrying tert-butyloxycarbonyl groups HOECHST AKTIENGESELLSCHAFT (DE) 1995-03-14 US disclosed
EP-0530469-A1 Process for the preparation of organic compounds carrying tert.-butoxycarbonyl groups HOECHST AKTIENGESELLSCHAFT (DE) 1993-03-10 EP disclosed
US-5030715-A Antibacterial agents; immunomodulators; auto immune diseases ROUSSEL UCLAF (FR) 1991-07-09 US disclosed
US-4169941-A ANTIBIOTICS, URETHANE-TYPE AMINO PROTECTION REACTION ABBOTT LABORATORIES (US) 1979-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240226115-A1 AXL INHIBITOR COMPOUNDS AXL, BTK, MERTK BCHE 4681/4885CHRM2 4396/4885CHRM1 4297/4885
US-20090163722-A1 N-TERT-BUTOXYCARBONYL-2-PYRROLIDINONES AND PRODUCTION METHOD THEREOF TERT, CBR1, TELO2 BCHE 514/4885CHRM2 1573/4885CHRM1 622/4885
US-20240246967-A1 AXL COMPOUNDS AXL, FLT3, BTK BCHE 4613/4885CHRM2 3883/4885CHRM1 3851/4885
US-20100280259-A1 N-Tert-Butoxycarbonyl-2-Pyrrolidinones and Production Method Thereof TERT, CBR1, TELO2 BCHE 514/4885CHRM2 1573/4885CHRM1 622/4885
US-11723897-B2 Fatty acids as anti-inflammatory agents ALOX15B, FFAR1, ALOX12 BCHE 1398/4885CHRM2 2845/4885CHRM1 2792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.